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ABSTRACT 
The aims of the this study were to investigate the effects of delayed onset muscle 
soreness (DOMS) following downhill running on. cycling power output and to 
determine the extent of any relationships between power output, strength, and DOMS. 
12 active male subjects (aged 18-25 years) were randomly assigned to either a test (n=7) 
or control (n=5) group. The test group performed a 5 x 8 minute downhill ru1ming 
protocol at a grade of -7% and a speed corresponding to 80% of the subjects age 
predicted heart rate maximum. Measurements of isometric knee extension and flexion 
strength, peak and average cycling power output (Wingate Test), muscle tenderness, 
muscle soreness and plasma creatine kinase (CK) were taken pre-run and 30 minutes, 
24, 72 and 120 hours post-run for both groups. The test group did not perform the 
downhill running protocol. 
The control group showed no significant changes in any of the testing variables across 
time. For the test group, significant decreases (p<.05) in mean knee extensor strength 
were observed 30 minutes (16.7%) and 24 hours (10.9%) post-run. Significant 
increases (p<.O I) in soreness and tenderness scores were also 30 minutes, 24, 72 and 
120 hours post-run, and 24 and 72 hours post-run respectively. Although changes in 
knee flexor strength, average power, peak power (9.8, 5.3 and 3.6% respectively) and 
plasma CK were observed in the test group post-run, these results were not significant. 
Variations in correlation coefficients were seen between the variables of flexor strength, 
extensor strength, peak power and average power, and tenderness and soreness over the 
testing occasions. In particular significant correlations from baseline testing (r' = 0.69) 
for extensor strength and average power were reduced 120 hours post-run (r' = 0.32). 
No significant correlations were seen between soreness or tenderness, in relation to 
power output or strength, however this result may reflect a variation in testing 
protocols, and the use of active subjects with possible protection against damage and 
soreness. 
Results show that peak power, average power and strength are reduced during periods 
of DOMS, however, q. direct relationship could not be confirmed from the current study 
without further investigation. 
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CHAPTER I INTRODUCTION 
The ability of an individual to produce muscular power is considered an essential 
element of sporting performance (Beckenholdt & Meyhew, 1983). The term muscular 
power is defined as the product of force and the velocity at which that force is applied 
(Kreighbaum & Barthels, 1990, p. I 06). As a result, the measurement of both 
mechanical power and work (work = force x displacement), has become standard for 
determining maximal power. Maximal power output of a muscle group is related to the 
capacity of anaerobic metabolism during exercise (Vanderwalle, Peres, Heller & 
Monod, !985). 
It has been suggested that the generation of muscular power may be reliant on either the 
existence of a large muscle mass or a high percentage of type lib muscle fibres 
(Manning, Dooly-Manning & Perrin, 1988; Narici, Roi, Landoni, Minetti & Cerretelli, 
1989). Additionally, the production of muscular force, and hence power, is closely 
correlated with muscle fibre length and muscle pennation (Scott & Winter, 1991 ). 
Consequently, studies relating to delayed onset muscle soreness (DOMS) have shown 
that disruption to the fibre structure caused by exercise, results in a significant decrease 
in muscular force production (Smith, eta!., I 994; Eston, Finney, Baker & Baltzopoulos, 
I 996). 
Muscular force alone, however, is not a common indicator associated with sporting 
performance. Rather, generation of dynamic force, or power, is generally correlated 
with performance in both individual events (i.e. high jump and judo) and pairs or teams 
events (i.e. tennis and soccer). Furthermore, the ability of an individual to sustain or 
repeatedly reproduce near maximal power during an event is another key factor in 
performance success (Beckenholdt & Meyhew, 1983). 
Since it has been shown that muscular force declines during periods of DOMS, it is 
reasonable to expect that maximal power production will also be negatively affected. 
However, little or no investigation has been carried out in this area. The purpose of the 
current study is to investigate whether power related performance is decreased during 
periods of DOMS, and identify whether a relationship exists between maximal power 
production, muscular strength, and muscle soreness following exercise. 
1.1 Research Questions 
I. Does maximal power production decrease during periods of delayed onset muscle 
soreness? 
2. Do relationships exist between changes in maximal power production, muscle 
strength and delayed muscle soreness following exercise? 
1.2 Hypotheses 
I. The test group will display greater DOMS and levels of plasma creatine kinase than 
the control group. 
2. Peak power output will be decreased in the test group compared to the control 
group. 
3. Average power will be decreased in the test group compared to the control group. 
4. A positive relationship will exist between the degree of DOMS and power output 
perfom1ance. 
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CHAPTER2 LITERATURE REVIEW 
2.1 Delayed Onset Muscle Soreness 
2.1.1 Definition 
Delayed onset muscle soreness (DOMS) is the sensation of discomfort or pain that can 
occur in any skeletal muscle following unaccustomed muscular exertion, with pain 
generally developing 1-2 days following exercise and subsiding 5-7 days post exercise 
(Armstrong, 1984; Miles & Clarkson, 1994). A characteristic of the pain associated 
with DOMS is that it is absent at rest and experienced when active movement or 
contraction tenses the muscle, or when direct pressure is placed on the muscle. In 
addition to soreness, DOMS clinically presents as electrically silent muscle shortening, 
stiffness, decreased flexibility and range of movement, and a decrease in maximal force 
production (Gulick & Kimura, 1996). 
2.1.2 Mechanisms of DOMS 
Throughout the literature a number of theories have been proposed to explain the 
mechanisms underlying DOMS, and while no one theory has been shown to be a sole 
contributor, others have received limited support from following investigators. 
Investigating authors (Newham, Mills, Quigley & Edwards, 1983; Thomas, Londeree, 
Lawson, Ziogas & Cox, 1994) have largely rejected the early idea that DOMS is caused 
by an accumulation of lactate within the exercised muscle. Opposition to the theory 
results from the observation that lactate production during exercise is not correlated 
with resulting sensations of DOMS. That is, exercise most commonly resulting in 
DOMS (eccentric exercise) is physiologically more efficient and results in lower lactate 
production levels than concentrically based exercise. Futhermore, lactate levels in both 
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the blood and muscle return to resting levels before the appearance of pain (Schwane, 
Watrous, Johnson & Armstrong, 1983). 
Similarly, the muscle spasm theory of Travel!, Rinzler and Herman (1942) has received 
limited support because of failure to duplicate their experimental findings (Abraham, 
1977). They (Travel! et al., 1942) proposed that the delayed pain occurred as a result of 
ischemia initiated by local tonic muscular spasm representative of a positive feedback 
nervous cycle. While this theory has been used to explain the stiffness commonly 
associated with DOMS (Miles & Clarkson, 1994), it has been concluded that it is 
unlikely to be the mechanism responsible for the delayed pain experienced in this 
condition (Gulick & Kimura, 1996). 
Other investigations relating to the sensation of DOMS are consistent in the reporting of 
two observations: 
l. That the mechanism responsible for DOMS is most likely initiated by mechanical 
factors as opposed to metabolic factors (Hough, 1902; Stauber, Clarkson, Fritz & 
Evans, 1990). 
2. That inflammation and enzyme efflux from muscle fibres is responsible for the 
activation and sensitisation of free nerve endings resulting in the sensation of 
DOMS (Pyne, 1994; Smith, 1991). 
It has been proposed that the observed muscle damage following exercise results in the 
stimulation of an inflammatory response causing the development of a muscle oedema 
and increases in muscle osmotic pressure, thus stimulating the sensation of pain (Pyne, 
1994; Smith, 1991 ). The delayed appearance of pain is therefore explained by the time 
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taken for noxious substances (such as calcium, histamine and potassium) to enter the 
microcirculation and extracellular space within the muscle, and for the inflanunatory 
response to occur (Stauber et al., 1990). 
2.1.3 Physiological Responses during DOMS 
2.1.3 .1 Creatine Kinase Response 
Creatine Kinase (CK) is an enzyme controlling anaerobic adenosine triphosphate (ATP) 
production from the phosphagen, or ATP-PC system, and is responsible for the 
reversible reaction: 
Creatine Phosphate+ ADP 
CK 
""' 
Creatine + A TP 
This system is used to replenish levels of A TP during strenuous exercise or short term, 
high intensity exercise (Powers & Howley, 1994, p. 34; McArdle, Katch & Katch, 
1996, p. I 03). 
Found in the brain, skeletal and cardiac muscle (Eston, Mickleborough & Baltzopoulos, 
1995, p. 90) elevated plasma CK following exercise is commonly used to indicate the 
existence of skeletal or cardiac muscle damage. The increase in plasma CK, however, 
is not directly related to the degree of muscle fibre necrosis (Kuipers, 1994; Newham, 
Jones & Edwards, 1983) with individual responses shown to occur (Clarkson, Nosaka & 
Braun, 1992). While the time course reported for increases in plasma CK following 
damaging exercise usually involves a steady rise to a peak 5-7 days post exercise 
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(Schwane, Johnson, Vandenakker & Armstrong, 1983), variations in both the time 
course and the degree of efflux have been demonstrated. 
Following a repeated stepping exercise, Newham, Jones et a!. (1983) reported both 
small, rapid (<24 hrs) plasma CK peaks, and greater magnitude, delayed rises (>4 days). 
A similar observation was reported by Clarkson et a!. (1992) following maximal 
eccentric actions of the forearm flexors. Clarkson et a!. also suggests that peak CK 
responses may vary according to exercise mode with peaks occurring most often 24hrs 
post exercise for downhill running as opposed to 4 days post exercise for high-force 
eccentric exercise. 
2.2 Strength and Power Changes following Eccentric Exercise 
Investigators of the effects of eccentric exercise on strength have demonstrated declines 
in maximal voluntary strength, maximal twitch and maximal tetanic tensions (Davies & 
White, 1981; Jones, Newham & Torgan, 1989; Talag, 1973 ). The strength loss is 
generally observed immediately post exercise with significant decreases still evident up 
to 4 days post exercise. Similarly, a study by Sargeant and Dolan (1987) reported 
decreases in both maximal voluntary strength and short term power output following 
eccentric exercise. Similar to strength declines, significant decreases in power output 
were seen immediately post exercise with an average recovery period of 4 days. 
Reductions in peak isokinetic torque during maximal voluntary contraction have also 
been observed following eccentric exercise (Eston eta!., 1996) with 30,90 and 160°/sec 
contractions showing peak torque declines similar to those reported for maximal 
isometric strength (Crenshaw, Thornell & Friden, 1994; Eston et a!., 1996; Macintyre, 
Reid, Lyster, Szasz & McKenzie, 1996). 
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The observed declines in strength and power are thought to be primarily the result of 
ultrastructural damage within the muscle (Brown, Child, Donnelly, Saxton & Day, 
1996; Eston et a!., 1995). Byrd, McCutcheon, Hodgson and Gollnick (1989) found that 
following high intensity exercise calcium uptake by the sarcoplasmic reticulum (SR) 
was reduced by up to 50%, and concluded that such a decrease was therefore a possible 
contributor to observed changes in muscle contractility. Similarly, Clarkson et a!. 
(1992) reported that a delay in the restoration of calcium levels following exercise 
would occur if the SR had sustained damage, therefore negatively influencing muscle 
force production. Damage noted to the myofibrillar Z-band and disruption of sarcomere 
length and functioning may further contribute to observed strength declines (Clarkson et 
a!.; Friden & Lieber, 1992) 
2.3 Protection against Muscle Damage 
While ultrastructural muscle damage is thought to be responsible for DOMS following 
unaccustomed, strenuous, or eccentric exercise (Armstrong, 1984), such damage is not 
only repairable, but may result in a structural adaptation, protecting the muscle against 
subsequent bouts of exercise for up to 6 weeks (Ebbeling & Clarkson, 1989). 
Investigations by Clarkson et a!. (1992) found that responses in plasma CK, soreness, 
swelling and strength loss were reduced following a second bout of eccentric exercise 
compared with the first bout performed six weeks prior. Similarly, Eston et a!. (1996) 
reported reductions in elevated plasma CK, muscle tenderness, and peak torque declines 
following a downhill treadmill run when preceded two weeks by repeated maximal 
eccentric activation of the knee extensors. 
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The mechanisms by which this observed protection occurs is not known, although it is 
thought to be partly due to strengthening of the muscle membranes and connective 
tissue (Ebbeling & Clarkson, 1994), and altered cellular and neurological factors 
(Clarkson et al., 1992). 
2.4 The Wingate Anaerobic Test 
The Wingate anaerobic test (WAnT) was developed in the 1970's by the Israeli Wingate 
Institute for Physical Education and Sport, and has become a standard measure for 
anaerobic muscle capacity (Inbar, Bar-Or & Skinner, 1996, p. l ). The most common 
protocol for the WAnT involves a 30 second all out effort on a cycle ergometer with a 
braking force set according to body weight (Bouchard, Taylor, Simoneau & Dulac, 
1991, p. 199). There are, however, variations of the protocol according to age and 
fitness (Inbar et al, 1996, p. 17). 
The test itself is designed to determine three specific parameters of anaerobic 
performance (Vandewalle et al., 1985, p. 223), these being: 
l. Mean power production (MP), 
2. Maximal or peak power production (PP), 
3. Fatigability or the fatigue index (FI). 
Power readings are determined at 5 second intervals throughout the 30 second test 
period with MP defined as the average work output for the 30 seconds, and PP the 
highest work output in a 5 second period. The rate of power decrease, or the FI is 
calculated (Sharp & Koutedakis, 1987, p. 1 0) according to the formula: 
8 
FI PP - minimum power X 100 
PP 
Results gained for MP are generally considered to be an indication of an individuals 
anaerobic capacity while PP is thought to represent predominately alactic or 
phosphagen metabolic capacity (Inbar, eta!., 1996, p. 12). 
Throughout the literature two main variations in the WAnT protocol can be identified, 
these being; 
I. Variations in braking loads, 
2. Variations in pedal crank length. 
2.4 .I Load Optimisation 
The most commonly used resistance for the WAnT protocol is equated at 75g·kg·BW-1 
(Bouchard eta!., 1991). Dolan and Bar-Or (1983), however, suggested that the braking 
load set during a WAnT may influence results for PP and MP recordings, particularly in 
highly anaerobically trained athletes. A study by Sharp and Koutedakis (1987) 
involving elite gymnasts, rowers and judo competitors also suggesting that results for 
MP and PP may have been underestimated for the judo players and gymnasts, with a 
higher resistance required to simulate normal competition and training conditions. 
Similarly Dotan et a! (1983) suggested that the optimal load for male and female 
physical education students is 87 g·kg·BW-1 and 85 g·kg·BW-1 respectively. The 
authors however concluded that small variation(± 8.5g·kg·BW'1) in loading resulted in 
insignificant deviations from an individuals true maximum power. 
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2.4.2 Cycle Crank Length 
Inbar et a!. (1996, p. 13) state that as with braking loads, pedal crank length may 
influence optimisation of such variables as muscle tension, torque, and the kinetic 
energy of the moving leg mass, therefore influencing MP and PP recordings. The 
authors suggest that pedal crank length should therefore 'theoretically' be varied 
according to an individuals leg length to allow for accuracy in recordings. 
Previous comments by Inbar, Dotan, Trousil and Dvir (1983) also indicate optimal 
crank length as being dependent on individual leg length. The authors concluded that a 
parabolic relationship exists between power output and crank length, and that variations 
in MP and PP consistently occur at different crank lengths. The conventional ergometer 
crank length of 17.5cm, however, was found to be close to that crank length (16.6cm) 
for optimal power. The authors therefore concluded that only when large variations 
from 'normal' height occurs, should crank length vary according to individual leg 
length. 
2.5 Summary 
Repeated eccentric contraction is commonly shown to cause muscle damage following 
exercise, with delayed onset muscle soreness (DOMS) and elevated plasma CK levels 
indicators of such damage. It has also been shown that during periods of DOMS 
maximal force production is significantly reduced. There have however been few 
investigations into the influence of DOMS on dynamic force, or power, which is more 
closely associated to sporting performance. Investigation of this relationship may 
therefore have significance to performance in power related sports. 
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CHAPTER3 METHOD 
3.1 Subjects 
Twelve male subjects aged between 18 and 25 were randomly assigned to either a 
control or a test group. All subjects were currently active in sport, however, individuals 
who regularly participated in distance running or eccentrically biased exercise were 
excluded because of the increased possibility of protection against muscle soreness. 
Subjects volunteered for the study and provided written informed consent (Appendix A) 
prior to testing. While subjects were encouraged not to participate in physical activity 
during the testing period, normal training commitments could be maintained where 
necessary. Subjects were also asked not to begin any unaccustomed activities or 
training in the week prior to testing. 
3.2 Equipment 
Monark Ergomedic 843E cycle ergometer 
Repco cycle ergometer 
Cybex 6000 isokenetic dynamometer 
Trackmaster TM-500 motor driven treadmill (modified) 
ACCUSPORT blood lactate analyser 
Reflotron analyser (Boehringer-Mannheim) 
Polar PE4000 heart rate monitor 
Myometer (Dobras) 
Capillary pipettor (Boehringer Mannheim) 
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3.3 Testing Protocols 
3.3.1 Testing Schedule 
Testing was completed over a 12 day (Figure 1) period with testing protocols identical 
for both the test and control groups. 
Day 
I 2 3 4 5 6 7 8 9 10 II 12 
Test Baseline (I) Baseline (2) Run 24 72 120 
hours hours hours 
Figure 1. Arrangement of testing protocol over a standard 12 day period 
Results for isometric strength and power output from the two baseline testing 
occassions for each of the 12 subjects were used for determination of the reliability of 
the testing protocol. Both groups performed the same series of tests with the exception 
that the test group performed a run protocol on the third testing occasion in addition to 
the isometric leg strength and power output protocol. Each baseline testing occasion, 
30 minutes, 24, 72, and 120 hours post-run occasion consisted of an isometric leg 
strength and power output protocol. Baseline figures used in comparisons across time 
were taken from each subjects highest averaged peak values for strength, and highest 
recording of peak power during either of the two baseline testing occasions. 
3.3.2 Run protocol 
Each subject in the test group completed an intermittent run protocol (as described by 
Eston et al., 1996) with the treadmill grade set a -7% (Figure 2). Subjects ran for 5 sets 
of 8 minutes with 2 minutes rest between sets during which time subjects were free to 
perform stretching exercises or walk around the room. Treadmill speed was adjusted at 
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the end of each 2 minute interval as required to maintain a heart rate equal to 80% of the 
subjects age predicted heart rate maximum. Water was provided ad libitum during the 
rest periods, and a fan available at request for subject comfort. Following the 
completion of the run protocol subjects were given a 30 minute rest before commencing 
the post-run isometric leg strength and power output protocols. 
Figure 2. Modified treadmill positioned at -7% grade for completion of downhill run 
protocol 
3.3.3 Isometric Leg Strength 
Maximal voluntary contraction (MVC) strength of the knee extensors and flexors was 
determined at 60° of knee flexion using a Cybex 6000 isokenetic dynamometer. 
Subjects were seated upright and secured with a seat belt style strap. Hip alignment was 
adjusted so that the line from the hip to the knee was perpendicular to the rotating arm 
of the dynamometer? and the axis of rotation of the arm was level with the lateral 
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condyle of the tibia. Additionally, a strap was seemed across the subjects thigh to 
prevent the leg lifting during each contraction (Figure 3). 
Figure 3. Subject secured in position at 60° of knee flexion during performance of a 
maximal voluntary contraction of the right knee extensors 
Verbal encomagement was given as subjects completed 3 x 5 sec MVC's of the knee 
extensors and 3 x 5 sec MVC's of the knee flexors, each MVC being separated by at 
least 5 sec rest. A 20 sec rest period was allowed between the 3 sets of MVC's, during 
which time feedback on performances in the previous set was given. 
3.3.4 Power Output 
Maximal power and average power was assessed by performance of a Wingate 
Anaerobic Test (WAnT). The protocol for this test consisted of a 30 sec all out effort 
on a Monark Ergomedic 843E cycle ergometer (Figure 4) with the resistance set at 75 g 
kg·' body mass a~ sug~ested by Inbar et al. (1996). 
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Prior to each WAnT protocol subjects completed a 5 minute warm up on a Repco cycle 
ergometer, performing intermittent exercise (30 sec exercise with 30 sec rest) to elicit a 
heart rate of approximately 150 beats per minute (bpm). This protocol was adopted as it 
has been suggested an intermittent warm up is the most effective for optimising 
performance in the WAnT (Inbar et al., 1996, p.8). A 3 minute rest was then allowed 
before the commencement ofthe WAnT. 
Figure 4. Example of subject positioning during performance of the Wingate Anaerobic 
Test 
Performance of the WAnT required subjects to begin pedaling maximally with no 
resistance. The resistance was added when the pedaling rate reached between 180 and 
200 RPM beginning the 30 sec test period. Subjects were verbally encouraged to 
maintain the pedal rate for the 30 sec after the load application. Once the 30 sec test 
period had elapsed the resistance was removed and the subjects began a 2-3 minute cool 
down. Seat height was adjusted for each subject and kept constant throughout the 
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testing period. All subjects were fitted with toe clips to allow for the exertion of force 
during both knee flexion and extension. 
3.4 Testing Measures 
3.4.1 Blood Lactate 
Plasma lactate concentration was determined prior to warm-up and 30 sees post exercise 
for each WAnT, and immediately pre and post run for the treadmill protocol. A 30!J.L 
blood sample was collected from the fingertip using a capillary pipette and analysed 
using an ACCUSPORT blood lactate analyser. 
3 .4.2 Heart Rate Monitoring 
Heart rate (HR) was monitored using a Polar PE4000, with the same monitor used for 
all subjects throughout the study. Recordings of HR were made immediately pre and 
post test for the WAnT. While HR was monitored for standardisation purposes during 
warm-up for the WAnT, no figures were recorded for statistical analysis. Additionally 
HR was recorded immediately pre-run, and at 2 minute intervals during the treadmill 
run protocol from which treadmill speed was adjusted. 
3.4.3 Creatine Kinase (CK) 
Plasma CK levels were determined immediately pre run and post run, and 24, 72, and 
120 hours post run for the test group, prior to the commencement of the isometric leg 
strength protocol. For the control group plasma CK was determined prior to the 
commencement of the isometric leg strength protocol on the run day equivalent, and 24, 
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72, and 120 hours post-run. A 30)..tL blood sample collected from the fingertip using a 
capillary pipette was analysed immediately using a Reflotron analyser (Behringer-
Mannheim). Where lactate and CK samples were to be analysed on the same occasion 
the first blood sample was used for lactate analysis and the second for plasma CK. 
3.4.4 Muscle Soreness and Tenderness 
Muscle soreness was analysed using a self report 1 (normal) to 10 (very very sore) scale 
(Smith et al., 1994) whilst walking for the various sites (Figure 5) on the gluteal, 
hamstring, quadricep, gastrocnemius and anterior tibialis muscle groups. 
• • 
• • 
• • 
(a) (I>) (d) 
Figure 5. Standard sites used during recordings for soreness and tenderness for the (a) 
gluteal and hamstrings (b) quadriceps (c) gastrocnemius and (d) anterior tibialis. 
Adapted from: Rogers, A. (1992). Textbook of anatomy. London : Churchill Livingstone. 
Muscle tenderness measurements were taken at the same sites as muscle soreness using 
a Dobras myometer. Values were recorded following soreness recordings and were 
taken with the subject in a non-weight bearing situation. Following a similar method to 
that described by Eston et al. (1996), the myometer was applied at each site and the 
pressure increased manually, with subjects asked to report when pain was perceived. If 
no pain was reported with the application of a ceiling value of 14.5 psi (lOOkPa), it was 
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assumed no tenderness was present. Soreness and tenderness ratings were taken 
immediately pre- and post-run, and 24, 72, and 120 hours post run. Ratings were 
determined prior to both the strength testing protocol and the WAnT. 
3.5 Statistical Analysis of Data 
Reliability of testing protocols was determined by calculation of the coefficient of 
variation of method error between the two baseline measures of strength and power 
output for all 12 subjects. 
Statistical analysis for muscle soreness and muscle tenderness over time was calculated 
using an averaged score for all sites within each muscle group. For correlation 
comparisons the mean of the averaged ratings was calculated to give single values for 
tenderness and soreness. 
Each dependant variable (muscle soreness, muscle tenderness, lactate, HR, strength, 
power and plasma CK) was statistically analysed using a two way ANOV A with 
repeated measures (time) test. Where a significant p value was obtained (p<.OS) 
between groups, independent sample t-test comparisons were conducted to determine 
those time intervals that were significantly different. Within group differences were 
determined using paired sample t-test. 
To assess the existence of relationships between the test variables of power, muscular 
strength, muscle soreness and muscle tenderness, a Pearson product moment correlation 
coefficient was calculated. For inter-subject comparison purposes, results of strength 
and power are presented in terms of body weight. The reliability of isometric leg 
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strength and power output results was determined by calculation of the coefficient of 
variation of method error, for results obtained on the two baseline testing occasions. All 
results from testing are reported as the mean (±SEM) with individual recordings for 
each ofthe testing variables given in Appendix D. 
3.6 Ethical Considerations 
Ethical approval for this study was granted by the Edith Cowan University Committee 
for the Conduct of Ethical Research. All subjects completed a medical questionnaire 
(Appendix B) and under went medical screening and provided written informed consent 
prior to testing. 
3. 7 Limitations and Delimitations 
3.7.1 Limitations 
The current study was dependent on the appearance of muscle soreness in the test 
group. While the protocol adopted was based on previous studies (Eston et a!., 1996; 
Schwane et a!., 1983) where soreness was successfully induced, this did not guarantee 
soreness occurring in all muscle groups of the current study. It is also necessary to 
assume that the subjects are performing maximally during the strength and power 
protocol on each testing occasion. No check will be conducted throughout the testing to 
confirm if subjects' MVC efforts were actually maximal, with heart rate the only guide 
of maximal performance during the power protocol. 
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3.7.2 Delimitations 
The subjects in the current study were not a true representation of the population for the 
following reasons: 
l. Only male subjects were tested 
2. Only subjects aged 18-25 years were tested 
3. Sedentary or highly trained individuals were excluded from testing 
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CHAPTER 4 RESULTS 
4.1 Reliability 
The coefficient of variation of method error for single repeated measures of isometric 
strength of the leg flexors, leg extensors and power output were 2.94%, 3.72%, and 
1.87% respectively. Data for the coefficient of variation for each parameter are given in 
Table I. There was a good reliability for the tests in question, with each test having a 
coefficient of variation less than 5%. 
Table I 
Coefficient of Variation of Method Error for Individual Testing Parameters 
Strength 
Left extension 
Left flexion 
Right extension 
Right flexion 
Power 
Coefficient of Variation of 
Method Error(%) 
4.04 
3.50 
3.08 
3.82 
Peak power 1.91 
Averagepower 2.15 
4.2 Subject Characteristics 
Table 2 reports mean values for age, height, weight, and activity levels for the test and 
control groups. No significant differences for subject characteristics were seen between 
the two groups with the exception of weight, with the control group significantly 
heavier. 
2! 
Table 2 
Subject Characteristics of Test and Control Group (mean+ SEM) 
Test group (n = 7) Control group (n = 5) 
Age (years) 19.1 ± 0.3 19.6±0.4 
Height (em) 183.4 ± 2.4 184.0 ± 3.7 
Weight (kg) 72.4 ± 1.8 83.8 ± 4.8 
Activity level (hr/week) 5.7 ± 1.8 5.2 ± 0.8 
Baseline values for isometric strength and power output normalised for body weight are 
shown in Figure 6, and demonstrate similar average strength and power output between 
groups. 
Baseline Strength and Power 
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Figure 6. Baseline values (mean SEM) between test (n=7) and control (n=5) groups for 
extensor and flexor strength, peak power and average power 
As strength of both limbs was very similar (less than 4% difference for flexors and 1% 
difference for extensors), results reported for strength are an average of combined limb 
strength for either the flexors or extensors. 
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4.3 Treadmill Run 
For the test group, mean values for HR and running speed during the treadmill run were 
159 ± 1 bpm and 12.7 ± 0.2 km/hr respectively. For each of the 8 minute periods within 
the run, no significant variations were recorded for either HR or running speed, with 
mean results shown in Figure 7. 
Heart Rate and Running Speed 
164 14.50 
162 14.00 ;;o c 
....... 13.50 :::J E 160 :::J 
c. ::;-
..0 158 13.00 <0 ...._... (/) 
Q) 156 12.50 -o o+J (1) ro 
..... (1) 
t:: 154 12.00 c. 
ro ~ Q) 152 11 .50 I 3 ..._ 
150 11.00 :::T ..3-
148 10.50 
2 3 4 5 
--Heart Rate 
Run Period 
-+- Speed 
Figure 7. Heart rate and running speeds (mean± SEM) for each 8 minute period of the 
treadmill run for the test group (n=7) 
The variation seen in running speed over the course of the protocol resulted from 
increases in heart rate, with treadmill speed adjusted at the completion of each 2 minute 
period as required to maintain a heart rate equal to 80% maximal (age predicted) hemt 
rate. Although mean blood lactates were slightly elevated post-run (3 .8 ± 0.5 mmolL-1) 
compared to pre-run (2.9 ± 0.3 mmolL-1) , the differences were not statistically 
significant. 
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4.4 Control Group Results 
Recordings for peak power and average power showed a range of less than 5% over the 
course of five tests, with 2.0% and 1.3% respective increases seen between baseline 
testing and 120 hours post-run (Figure 8). A larger, range in results was seen for flexor 
and extensor strength across time, with a 5. 9% decrease seen for the flexors and a 6. 1% 
increase for the extensors (Figure 9), however these changes were not statistically 
significant. 
Control Group Power Output 
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Figure 8. Peak power and average power (mean± SEM) across time for the control 
group (n=5) 
.• 
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Figure 9. Extensor strength and flexor strength (mean± SEM) across time for the 
control group (n=5) 
Within subject recordings for plasma CK remained within the 'normal' range of24-195 
U/I (Boehringer-Mannheim, n.d.) across testing occasions, showing no significant 
variations. As expected, control subjects reported no evidence of increased soreness or 
tenderness throughout the testing period. 
4.5 Test Group Results 
4.5.1 Strength 
Significant decreases in extensor strength were seen 24 hours post-run, with highly 
significant decreases seen 30 minutes post-run (Figure 10). While a similar decrease 
was seen in relation to flexor strength (Figure 11 ), results did not prove statistically 
significant. 
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Figure 10. Extensor strength (as a percentage of baseline) across each testing occasion 
(mean± SEM) for the test group(-+-). The shaded area represents SEM of extensor 
strength for the control group over the testing period 
* p<.05 
Test Group Flexor Strength 
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Figure 11. Flexor strength (as a percentage of baseline) across each testing occasion 
(mean± SEM) for the test group ( -+-). The shaded area represents SEM of flexor 
strength for the control group over the testing period 
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120 
Whist recovery of extensor strength above baseline recordings (5% increase) was seen 
for the test group, flexor strength still remained below baseline values ( -1.5%) by the 
final testing occasion 120 hours post-run. It can also be seen that a linear trend for 
recovery occurred in relation to both flexors and extensors strength. 
4.5.2 Power Output 
Figmes 12 and 13 show a mean reduction 30 minutes post-run for the test group in peak 
power and average power respectively. Although 3.6% and 5.3% declines in peak and 
average power occmTed post-run, the decreases were not significant. 
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Figure 12. Peak power (as a percentage of baseline) across each testing occasion (mean 
± SEM) for the test group(-+-). The shaded area represents SEM for peak power of 
the control group over the testing period 
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Test Group Average Power 
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Figure 13. Average power (as a percentage of baseline) across each testing occasion 
(mean ± SEM) for the test group (-+-). The shaded area represents SEM for average 
power of the control group across the testing period 
Similar to the decreases in strength, the largest declines in peak and average power were 
seen 30 minutes post-run, with recovery occurring over subsequent testing occasions. 
As with extensor strength final recordings for peak power showed recovery above 
baseline values (+4%), while recovery for average power, which showed a percentage 
greater reduction, still remained incomplete (-1.6%) 120 hours post-run. 
4.5.2.1 Pre and Post Wingate Lactate and Heart Rate CHR) Recordings 
Results for the post Wingate test lactate and HR recordings showed no significant 
variations either between groups or within groups across time. Figure 14 and 15 show 
mean results for post Wingate lactate and heart rate recordings respectively. 
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Figure 14. Post Wingate blood lactate recordings across time for the test (n=7) and 
control (n=5) groups (mean± SEM) 
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Figure 15. Post Wingate heart rate recordings across time for the test (n=7) and control 
(n=5) groups (mean± SEM) 
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4.5.3 Plasma CK 
Although a mean result above the upper limit of normal (195 U/1) was recorded for the 
test group on each occasion post-run, no significant differences were seen between the 
two groups across time. Within the test group however, plasma CK recordings were 
shown to be significantly increased 30 minutes, 24, 72 and 120 hours post-1un. It was 
notable that variations in the magnitude of plasma CK efflux were also seen within the 
test group (Figure 16) with recordings 24 hours post-run ranging from 116 UII to 1400 
U/I. 
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Figure 16. Plasma CK activity in the 7 test subjects, and the group mean activity, pre 
and post run, and 24, 72 and 120 hours post-run 
4.5.4 Soreness and Tenderness 
Results for mean soreness and tenderness show the greatest values recorded 24 hours 
post-run, and decreasing values recorded over the remaining testing occasions. 
Significant differences between the two groups were recorded on all testing occasions 
post-run for soreness (Figure 17), and 24 and 72 hours post-run for tenderness (Figure 
18). 
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Figure 17. Mean soreness for individual muscle groups, and overall mean soreness 
results across time for the test group (n=7) 
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Figure 18. Mean tenderness for individual muscle groups, and overall mean tenderness 
results across time for the test group (n=7) 
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Similar time course results for soreness and tenderness scores were recorded for 
individual muscle groups, with no significant differences between muscle groups seen 
across testing occasions. Similarly, no significant variations in recordings were seen for 
individual sites within the same muscle group. High recordings for both tenderness 
and soreness, however, were seen for the quadriceps 24 and 72 hours post-run, relative 
to the other muscle groups tested. 
4.6 Relationship between Testing Variables 
Performance results for flexor and extensor strength showed significant correlations on 
all testing occasions post-run, with the exception of 24 hours post-run, where 
correlations were not significant. Figure 19 shows correlations of extensor strength and 
flexor strength for baseline recordings, and for recordings 24 hours post-run, where the 
reduced relationship was observed. 
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Correlations for extensor strength and average power, flexor strength and average 
power, and extensor strength and peak power, all demonstrated similar interactions for 
testing variables across time. Significant correlations were seen on all occasions for 
flexor strength and average power with the exception of 120 hours post-run, while 
significant results for extensor strength and average power, and extensor strength and 
peak power, were seen on all testing occasions with the exception of 72 and 120 hours 
post-run. Figure 20 shows con·elations for extensor strength and average power for 
baseline testing and 120 hours post -run. 
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Figure 20. Changing relationship between extensor strength and average power as 
evident by a changing correlation for baseline and 120 hours post-run testing results 
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There were no significant con·elations between soreness or tenderness and the variables 
of flexor strength, extensor strength, peak power, or average power. Correlations 
between the two variables however, showed significant negative correlations 24 hours 
(r2 = .86) and 72 hours(~= .44) post-run. 
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CHAPTERS DISCUSSION 
5.1 Effect ofDOMS on Power Output 
The main focus of the current study was to assess the influence of DOMS on power 
output. As hypothesised, the test group showed a decrease in both average and peak 
power, and reported greater sensations of DOMS following the treadmill run. While 
previous investigations (Sargeant & Dolan, 1987) have reported a mean decrease in 
short term anaerobic power output of 33% 24 hours following a downhill walking 
exercise to fatigue, the contribution of DOMS to these observed decreases were not 
considered. Similar to the findings of Sargeant and Dolan ( 1987), results from the 
current study showed that both average power and peak power were reduced in the test 
group following a downhill run, although declines were greatest 30 minutes following 
the run, rather than 24 hours post-exercise. While Sargeant and Dolan reached no 
definite conclusions as to the cause of the decreased power, they suggested that it may 
result from an inability of the contracting muscles to maintain calcium homeostasis. It 
is suggested that following damaging exercise, calcium release from the sarcoplasmic 
reticulum (SR) is impaired, and restoration of calcium via the calcium pump following 
contraction is reduced (Sargeant & Dolan, 1987). A delay or fault in the excitation 
coupling of the muscle would therefore reduce the action potential created across the 
muscle fibre sarcolemma, and diminish the contractility of the muscle (Brown et al., 
1996). Investigations by Byrd et al. (1989) also suggest that substrate accumulation or 
depletion (including PCr and glycogen) following damaging exercise may influence the 
activity of the calcium - ATPase pump, resulting in further depression of SR 
fi.mctioning and muscle contractility. 
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It has also been suggested (Talag, 1973) that decreases in performance seen following 
eccentric exercise are the direct result of pain preventing the subject from exercising 
maximally. Evidence from the current study and previous investigations (Newham, 
Mills et a!., 1983) however suggests otherwise since there were no significant 
correlations. between soreness, and either peak power or average power. Furthermore, 
the greatest declines of both strength and power were seen 3 0 minutes post -run, while 
both muscle soreness and tenderness peaked 24 hours post -run. 
Muscular strength has also been shown to decline following eccentric exercise when 
force production was measured during electrical stimulation of the exercised muscle 
(Davies & White, 1981 ). By performing such experiments investigators are able to 
compare directly force production during a constant stimulus and essentially remove to 
subjects perceptions and participation during the contraction. Additionally, if soreness 
or pain in the current study had caused the subjects not to perform with maximal effort, 
it would seem reasonable to assume that a decrease in post exercise hemt rates and 
lactate results would be recorded. This, however, did not occur. It is therefore 
suggested that the observed power decrements, particularly that of average power, were 
not the result of decreased effort due to soreness, but to some other factor. 
While from the current results it is not possible to comment on the suggestions that 
muscular performance declines occur as a result of altered calcium function, they do 
suggest the need for further investigation. Of particular interest is the pOssibility of a 
role of calcium in power declines as proposed by (Sargeant & Dolan, 1987) and the 
appearance of calcium as a noxious substance resulting in DOMS (Stauber et a!., 1990). 
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While performance decrements and DOMS are often studied together, it has still not 
been firmly established if the two are actually related. 
5.2 · Relationship between Power Production, Muscle Strength and DOMS 
A secondary focus of the current study was to assess the degree to which relationships 
exist between the variables of maximal power production, muscle strength and DOMS 
following exercise. During baseline testing, those subjects with the greatest isometric 
strength (for either the flexors or extensors) generally displayed the higher recordings 
for peak power, evident from the baseline correlation results. Therefore, it could be 
considered that a positive relationship between peak power and strength does exist. 
However, following the eccentrically biased run protocol, these correlations decreased, 
suggesting little or no relationship between the variables. A similar observation also 
occurred in relation to correlations between flexor and extensor strengths alone. One 
possible explanation for these results is a difference in muscle group activation during 
the downhill run, isometric leg strength, and power output protocols. 
It has been suggested that the muscles subjected to the most damage, and therefore 
liable to show the greater performance decrements, are those that perform the greater 
amounts of eccentric work during exercise (Ebbeling & Clarkson, 1989, Friden & 
Lieber, 1992). Results of the cunent study for strength and power following the 
downhill run would therefore, be dependent on the degree to which muscles in which 
damage was induced during the run, were then involved during the subsequent strength 
and power protocols. 
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5.2.1 Biomechanics of Downhill Running, Knee Extension and Flexion, and Cycling 
Kinematic studies of downhill running have shown that the extensors of the knee, 
gastrocnemius, tibialis anterior, extensor hallucis longus, and extensor digitorurn longus 
are all activated eccentrically, with DOMS usually noted in the gluteals, quadriceps, and 
the anterior and posterior tibial muscles (Eston et a!., 1995). 
The strength testing protocol adopted involved the principle knee extensors and flexor 
muscle groups, these being rectus femoris, vastus lateralis, vastus intermedius, and 
vastus medialis for extension, and biceps femoris, semitendinosus, and semimebranosus 
for flexion. Additionally, extension is assisted by the synergist muscle tensor fasciae 
latae, and flexion by gracilis, sartorius, poplitues, gastrocnemius and plantaris (Rogers, 
1992, p. 299-230; Williams, Warwick, Dyson & Bannister, 1989, p. 533). 
In contrast to both of these protocols, a greater range of muscle group activation occurs 
during a cycling action with recruitment of the flexors and extensors of the hip and 
ankle occurring (Gregor, Komi & Jarvinen, 1987; Hull & Hawkins, 1990). In addition 
to the muscles involved in knee flexion and extension, tibialis anterior, soleus, iliacas, 
psoas and gluteus maximus have also been shown to contribute to movement at 
different phases of the pedalling cycle (Hamill & Knutzen, 1995). In particular, gluteus 
maximus contributes to approximately 20% of the mechanical energy produced by the 
muscles during I cycle action, occurring predominately in the downstroke phase 
(Raasch, Zajac, Ma & Levine, 1997). 
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5.2.2 Biomechanical Relationship between Adopted Testing Protocol 
From the biomechanics of the testing protocol, it can be seen that differences exist 
between the muscle activation patterns for each of the three protocols. In particular, the 
quadriceps and the gastrocnemius are the only major contributors to mechanical work 
during the three different protocols. The quadriceps and the hamstring muscle groups 
being the only common contributors during the strength and power protocols. This may 
explain why a significant decrease between the two groups was seen in extensor 
strength only, post -run, and not flexor strength. The large contribution by the activity 
of smaller muscles (including tibialis anterior and soleus) in the power output of a 
cycling action, relative to downhill running may explain the smaller reductions seen in 
peak power and average power post-run. 
One of the features of this study was the large variability seen in the responses to 
downhill running, despite a standardised protocol being used for each of the test 
subjects. This however, may be due to various factors that could contribute to a 
variation in the degree of damage, and therefore soreness. These include differences in 
running style, and varying levels of protection against the development of muscle 
damage and soreness. 
5.2.2.1 Variations in Running Styles 
When comparing the running action of downhill and level running, the main differences 
involve the angle of the knee and ankle joints between the foot strike and peak flexion 
angle. As a result, the period of negative or eccentric work for the knee and ankle as a 
percentage of total stance time is significantly greater during downhill running (Eston et 
a!., 1995). The more eccentric work performed, the more damage and therefore 
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soreness that can be expected. Additionally, a large portion of injuries caused during 
running can be linked to gait irregularities, particularly when joint problems result in 
increased tensions and stresses on the muscles (Millar, 1994). The sites and severity of 
these injuries dependent on the nature and severity ofthe irregularity. 
Variation in stride length may alter the total period of eccentric work performed during 
downhill running, while variations in running gait could influence the injury patterning 
and the susceptibility to damage. Based on this, it would then seem reasonable that 
variations between test subjects in terms of both stride length and gait have the potential 
to influence the severity and pattern of damage, and therefore soreness, seen following 
the treadmill run. These concepts would also explain the variations in strength and 
power loss between subjects. Further investigation of running style (including stride 
length and time in the support phase) and the patterning of soreness and damage 
however, are required to fully assess the degree to which the two interact. 
5.2.2.2 Susceptibility to Exercise-Induced Muscle Damage 
Numerous studies (Ebbeling & Clarkson, 1989; Smith et a!, 1994) have been conducted 
focusing on muscle adaptation to repeated bouts of exercise, and the reductions in the 
normal responses seen post exercise. The results generally show that plasma CK 
responses are substantially reduced, as is the reporting of muscle soreness following 
subsequent exercise bouts (Eston et a!., 1996; Schwane, Williams & Sloan, 1987). 
With regard to strength decrements, there is little evidence that prior exercise provides 
protection against strength loss, but rather, the time taken for strength to recover is 
reduced (Newham, Jones & Clarkson, 1987; Smith eta!.). 
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During the current study, strength declines reached near full recovery ( <2% decline) by 
72 hours post-run, a shorter recovery than those reported previously (Macintyre et al., 
1996; Smith et al., 1994) for similar strength decline observations. Additionally, 
relatively low plasma CK responses were evident in 3 of the 7 test subjects, and low 
mean ( <4) scores for soreness were reported for all testing occasions. Given that the 
subjects in the current study were active in different modes of sports, and for varying 
lengths of time per week, different levels of past exposure the damaging exercise, and 
thus protection could be expected. For this reason, it is possible that the run protocol 
used in the current study was not of a sufficient duration and/or grade, to induce 
substantial damage in all of the subjects. 
5.3 Muscle Soreness and Tenderness 
In the present study subjects were asked to rate their soreness whilst walking for various 
sites on the gluteal, hamstring, gastrocnemius and anterior tibialis muscle. A tenderness 
score was also determined using a myometer where force is applied to the muscle and 
subjects asked to report the moment pain is perceived. As hypothesised, and consistent 
with the findings of previous investigators (Eston et al., 1995; Schwane, Johnson et al., 
1983), the test group reported greater DOMS following the downhill run protocol. 
Additionally, muscle tenderness was also noted for the same sites as muscle soreness, 
although the degree of soreness and tendemess were not always related. 
Throughout the literature, two different methods of determining muscle soreness are 
generally used. The first involves the method adopted in the current study where 
subjects are asked to rate soreness using a linear scale, I representing no soreness and 
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10 very, very sore muscles (Smith et al., 1994). The second method involves subjects 
rating soreness during self-palpation of the muscle where 0 = a complete absence of 
soreness; 1 = light pain felt only on palpation; 2 = moderate pain, some stiffuess, and/or 
weakness, especially during movement; 3 = severe pain that limits the range of motion 
(Abraham, 1977; Schwane, Johnson et al., 1983). However, as one of the clinical 
symptoms associated with DOMS is the presence of palpation tenderness (Gulick & 
Kimura, 1996), the second method described for soreness assessment could be 
considered a combination of a soreness scale and a tenderness scale. 
While muscle tenderness evaluation has been reported by various authors (Edwards, 
Mills & Newham, 1981; Eston et al., 1996) in relation to eccentric exercise and muscle 
damage, most neglect to distinguish between soreness and tenderness. Throughout the 
literature, soreness is generally referred to as pain occuring in the muscle during 
movement (Armstrong, 1984; Miles & Clarkson, 1994) Tenderness however is pain felt 
only when direct pressure is placed on the muscle (Eston et a!). In addition, most 
studies to date evaluate either soreness or tenderness, and not both together. 
Previous studies (Franklin, Currier & Franklin, 1991; Macintyre et al., 1996) 
investigating DOMS have generally shown muscle soreness to be greatest 2 days post 
exercise and subsiding 5-7 days post exercise. While subjects in the current study were 
not tested 2 days post-run, muscle soreness was shown to be greatest 24 or 72 hours 
post-run when compared to 30 minutes and 120 hours post-run, indicating a similar 
soreness pattern to those which have been reported. Consistent with the findings of 
Gleeson, Blannin, Zhu, Brooks and Cave (1995) soreness was reported in all four of the 
muscle groups, although greater (but not significant) soreness was generally reported in 
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the gastrocnemius, gluteal, and quadriceps muscle groups. Muscle tenderness was also 
reported in the test group post-run, although not immediately as with soreness, with 
peak tenderness recordings occurring 24 hours post-run similar to the findings of Jones, 
Newham and Torgan (1981). 
Results of the current study indicated tenderness to be both delayed in its appearance, 
and to have a similar recovery period as DOMS. Also, soreness and tenderness were 
shown to be highly correlated 24 hours post-run, while correlations 72 and 120 hours 
post-run were not as highly correlated. It has been suggested (Edwards et a!., 1981; 
Newham, Mills et a!., 1983) that tenderness associated with DOMS occurs most 
commonly in the musculotendinous junction, as opposed to being reported equally 
throughout the deeper tissue of the muscle as in DOMS. This however was not seen in 
the current study, with no significant differences seen for tenderness values at any site 
across the various muscle groups examined. Based on the literature relating to the 
mechanisms of DOMS, the sensation of soreness is most likely a result of type IV fibre 
stimulation, or that stimulation resulting in longer lasting, dull sensations of pain. In 
contrast, the short, sharp pain usually reported during tenderness evaluations may 
represent a type III fibre stimulation (Carlsson & Pellettieri, 1982; Terenios, 1987; 
Wall, 1987). 
As a significant correlation between soreness and tenderness was only observed 24 and 
72 hours post-run it would suggest the possibility that one sensation may exist without 
the other. Additionally, maximum tenderness values were frequently reported for a site 
within a muscle that was repmied as being only mildly sore (score of 5 or 6 out of 10). 
Due to the relative absence of literature directly comparing soreness and tenderness, 
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further investigation would be required before suggestions of a link between the two 
sensations could be made, or alternately, before the two sensations could be 
appropriately separated. 
5.4 CK Responses 
It was hypothesised that the test group would display higher levels of plasma CK than 
the control group. The results, although demonstrating raised plasma CK for each of 
the post -run time periods in the test group, did not prove statistically significant. This is 
most likely the result of an insufficient sample size, given the variability of plasma CK 
responses seen in the test group. There was however an increase in plasma CK seen 
across time within the test group, with significant increases seen immediately, 24, 72, 
and 120 hours post-run. 
In support of Clarkson et al. (1992), a peak plasma CK response occurred most often 24 
hours post-run with levels returning to normal range by 72 hours post-run. Clarkson et 
al. also suggested, that those individuals who could be classified as low plasma CK 
responders, also demonstrated lower strength declines and lower ratings of soreness. 
These observations however, were not supported by the results of the current study, 
with no significant correlations observed between the change in plasma CK and changes 
in soreness, strength or peak power. 
5. 5 Lactate Responses 
Results from the current study showed no changes in the post Wingate test lactate levels 
for the test group following the downhill run. Previous studies (Gleeson et al., !995; 
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Gleeson, Blannin, Walsh, Field & Pritchard, 1998) focusing on lactate production 
during submaximal exercise following an eccentric bout of exercise, have shown post 
damage exercise lactate levels to increase. It is unclear why a similar increase in lactate 
was not seen during the cunent study. 
As previously discussed in relation to strength and power declines, it is possible that the 
lack of any observable change in lactate production was a consequence of the subjects 
being protected against muscle damage. It is suggested that the damage seen following 
eccentric exercise occurs predominantly in the type II fibres (Lieber & Friden, 1988), 
and more specifically in the type Ilb fibre sub-group, which is considered to be the fibre 
responsible for high levels of lactate production during exercise (McArdle et al., 1996, 
p. 124; Fox, Bowers & Foss, 1993, p. 107). Investigations of lactate production 
following eccentric and concentric exercise bouts have shown significant increases in 
submaximal exercise lactate levels 48 hours following the eccentric bout of exercise 
only (Gleeson et al., 1995 & 1998). These increases were suggested as being the result 
of one or more of the following mechanisms: 
1. An increased rate of efflux of lactate from the working muscle due to increased 
muscle membrane permeability. 
2. A greater metabolic strain on the undamaged muscle fibres or. 
3. An altered recruitment pattern with greater reliance on type II fibres. 
It is however not thought to be the result of impaired oxygen extraction within the 
muscle as oxygen efficiency following damaging exercise remains unchanged (Gleeson 
et al., 1995 & 1998). In support of this, a study by Essen-Gustavsson and Thornell 
(1994) showed significantly higher plasma lactate concentrations during submaximal 
exercise in racehorses that had been identified as having myofibrillar and cytoskeletal 
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alterations of the type lib fibres. It is possible that subjects in the current study did not 
experience sufficient muscle fibre injury to cause altered lactate production during the 
subsequent Wingate tests. Further investigation would be required to determine if 
energy production and efficiency are altered during supramaximal exercise following 
eccentric work. 
Using oxygen consumption analysis during exercise following a prior bout of eccentric 
exercise, various authors (Kavanagh & Jacobs, 1988; Serresse, Lortie, Bouchard & 
Boulay; Smith & Hill, 1991) have investigated the relative contributions of the three 
energy systems to energy production· during maximal and supramaximal work. Using 
the same technique it would therefore be possible detetmine if any changes in the 
percentage contribution of each system occurred following an eccentric bout of 
exercise, rather than only comparing post exercise lactate concentrations. 
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CHAPTER6 SUMMARY AND CONCLUSIONS 
It is acknowledged that while the results for changes in flexor strength, average power, 
peak power and plasma CK between groups following the downhill run were not 
significant, this probably reflects the small sample size used in the study. It is also 
understood that a major factor responsible for the variation in responses, and to an 
extent, the low level of significant findings, is related to the use of active subjects who 
were likely to have developed protection against muscle damage and soreness. 
A notable observation from the current study is the need to closely consider the protocol 
adopted for inducing muscle soreness when testing subsequent performance declines. 
Results from the current study were greatly influenced by the biomechanical differences 
between the running protocol used to induce soreness, and the cycling protocol adopted 
for power output determination. It is likely that more significant results would be seen 
if (1) power output was determined via a running protocol, or (2) muscle soreness was 
induced using a cycling protocol. 
From the results, however, it would appear that power output is decreased during 
periods of DOMS, although it is inconclusive as the whether power output declines 
more than strength, and to what extent the variables of strength, power and soreness are 
related. Based on the findings it is suggested, that the eccentrically biased treadmill run 
performed by the test group was responsible for the observed changes in flexor strength, 
extensor strength, average power, peak power, soreness, tenderness, and plasma CK. 
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The results of the current study also suggest the need for further investigation into 
several aspects of DOMS and muscle damage following eccentric exercise. In 
particular: 
I. Investigation of the possibility of a direct correlation between soreness and 
tenderness, and performance declines. 
2. The distinction between sensations of soreness and tenderness following damaging 
exerc1se. 
3. Closer consideration of the involvement of calcium as a mechanism in the sensation 
ofDOMS, and decreases in strength and power. 
4. Further investigation of the patterning of damage and soreness following eccentric 
exercise, with particular focus on the influence of biomechanical variations between 
individuals. 
5. More thorough investigation of lactate production, energy system contributions, and 
oxygen efficiency during supramaximal exercise, following damaging exercise. 
6. Further investigation into the time course and nature of protection against muscle 
damage. 
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APPENDIX A INFORMED CONSENT FORM 
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INFORMED CONSENT FORM 
An investigation of changes in muscular power associated with delayed onset muscle 
soreness (DOMS') 
The mm of this research is to determine whether power related performance is 
decreased during periods of DOMS, and if relationships exist between maximal power 
production, muscular strength and DOMS following exercise. 
The study will be conducted over a 2 week period at the Joondalup campus of Edith 
Cowan University, and as a subject you will be randomly assigned to one of two groups. 
Testing will consist of a total of six visits to the laboratory for both groups. 
As a test group subject you will be asked to complete 3 different testing protocol, 
involving I treadmill run (5 x 8 min with 2 min rest intervals), 6 Wingate anaerobic 
tests, and 6 maximal isometric strength tests. The treadmill protocol will involve 
running at -7% grade, at a pace equivalent to 80% of your age predicted heart rate 
maximum. Each Wingate test will involve a 30 second all out maximal effmt cycle 
with a resistance set according to your body weight. Each isometric strength test will 
involve 6 maximal contractions at 60° of knee flexion. As a control group subject you 
will be asked to complete only the 6 Wingate anaerobic tests and 6 maximal isometric 
strength tests. As a subject in either group you will also be required to undergo medical 
screening prior to participation. 
Blood for lactate and creatine kinase levels will be taken a maximum of 16 occasions 
and will involve 30 microlitre whole blood samples from a finger prick. 
You may experience some degree of muscle soreness and muscle stiffuess in the days 
following the treadmill run, however this should subside within 5-7 days post run. 
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All of your personal infonnation and tests results are confidential and will not be used 
for any other purpose other than the current study. All information will be kept under 
lock and key, with each subject being assigned a numbered code known only to the 
researchers. Additionally, no data analysis will include any name or information that 
may identify you specifically as a subject. 
It is asked that you do not make any major changes to diet or exercise during the test 
period as this may influence results. Participation in the study is completely voluntary 
and you may withdraw at any time, for any reason. 
Any questions concerning the current study can be directed to: 
Cannel Nottle 
Dr. Paul Sacco 
 (Postgraduate Student) 
Research Supervisor) 
I (the participant) have read the informed consent above, and any questions have been 
answered to my satisfaction. I have obtained medical clearance specific to participation 
in this study and I agree to participate realising that I may withdraw at any time. 
I agree that the research data obtained from this study may be published, provided I am 
not identifiable. 
Participant Date 
Investigator Date 
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Medical Questionnaire 
The following questionnaire is designed to establish a background of your medical history, and identity any 
injury or illness that may influence your testing or performance. 
Please answer all questions as accurately as possible and if you are unsure about any thing please ask. 
All information provided is strictly confidential. 
Personal Details 
Name: 
DOB: Sex: 
Height: Weight: 
Medical History 
Have you ever had, or do you cmTently have any of the following? 
High or abnonnal blood pressure 
High cholesterol 
Rheumatic fever 
Heart abnormalities 
Asthma 
Diabetes 
Epilepsy 
Back pain 
Neck pain 
Severe allergies 
Any infectious diseases 
Are you currently on any medications? 
Have you had the flu in the last two 
weeks? 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
y 
If you answered YES please give details 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
If you answered YES please give details 
y N 
y N 
57 
Have you recently bad any injuries or 
accidents? 
Do you have any recurring muscle or 
joint injuries? 
Is there any other condition not 
previously mentioned which may affect 
your exercise performance? 
Family History 
y N 
y N 
Are any of the following known to exist in your family? 
Cardiac disease y 
Pulmonary disease y 
Stroke y 
Lifestyle Habits 
Do you exercise regularly? 
lfYES how many hours per week? 
Do you smoke tobacco or any other nicotine 
products 
If YES please how much per day? 
Do you consume alcohol? 
If YES how many standard drinks per week? 
Do you consume tea and or coffee? 
If YES how many cups per day? 
Do you take any recreational drugs? 
If YES how much or how often per week? 
Declaration 
N 
N 
N 
If you answered YES please give details 
y N 
y N 
y N 
y N 
y N 
I acknowledge that the information provided on this form, is to the best of my knowledge, a true and 
accurate indication of my current state of health. 
Name: Date: 
Signature: 
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Name: Group: ID: 
Age: Height: Weight: 
Pre-run Period 
Triall 
Date: Time: 
Strength 
Extensors Flexors 
Left Right Left Right 
Rep I 
Rep 2 
Rep 3 
Max. Force 
Wingate 
Pre test La: HR: 
RPM at start : 
Time 5 10 15 20 25 30 
RPM 
-~~~-
Power 
Peak power (W) Peak power/kg (W /kg) 
Minimum power (W) 
~--~-
Minimum power/kg (W /kg) 
Average power (W) Average power/kg (W /kg) 
Power drop (W/s) Power drop/kg (W /slkg) 
Post test La: HR: 
Trial2 
Date: Time: 
Strength 
Extensors Flexors 
Left Right Left Right 
Rep I 
Rep2 
Rep 3 
Max. Force 
Wingate 
Pre test La: HR: 
RPM at start : 
Time 5 10 15 20 25 30 
RPM 
Power 
Peak power (W) Peak power/kg (W /kg) 
Minimum power (W) Minimum power/kg (W/kg) 
Average power (W) Average power/kg (W /kg) 
Power drop (W/s) Power drop/kg (W /s/kg) 
Post test La: HR: 
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Name: __________________ __ 
Run Period 
Creatine Kinase 
Pre-run 
Lactate 
Pre-run 
Muscle Soreness 
Soreness Gluteals 
Left 
Right 
Tenderness 
Left 
Right 
I 
L 
Run- HR and Speed 
Pre-run 
Quad Hamstring 
I 
Group: ________ _ 
Post-run 
Post-run 
Calf A.Tib Gluteals 
I I I I 
I I I I 
Minute 
I Set Measure 2 4 6 8 
I l HR '--~---1---------------- ---------------- ----
Speed 
I Rest HR 
I 2 L----"'-------1- _filL 
Speed 
I Rest HR 
I 3 '-----"---1-~-- - - -
Speed 
I Rest HR 
l 4 HR ~--~----!,-C:Speed 
I Rest HR 
I 5 HR ~---''------1 Speed 
I End HR 
Post-run Wingate 
Pre test La: 
------
RPM at start : 
Time 
RPM 
Power 
Peak power (W) 
Minimum power (W) 
Average power (W) 
Power drop (W/s) 
5 
Post test La: __________ __ 
Post-run Strength 
HR: ___ _ 
lO 15 
Peak power/kg (Wikg) 
Minimum power/kg (W /kg) 
Average power/kg (W /kg) 
Power drop/kg (W/s/kg) 
HR: --------
20 
Extensors Flexors 
Quad 
25 
Left Right Left Right 
Rep I 
Rep 2 
Rep 3 
Max. Force 
61 
ID: -----------
Post-run 
Hamstring Calf ATib 
I I I I 
I I 
30 
Name: ____________________ _ Group: _____ _ 
Post-run Period 
Dayl 
Date: 
Creatine Kinase 
Muscle Soreness 
Soreness 
Left 
Right 
Tenderness 
Left 
Right 
Strength 
Gluteals 
Time: ------------~ 
Quad Hamstring Calf A Tib 
I I 
I 
I 
Extensors Flexors 
Left Right Left Right 
Rep I 
Rep2 
Rep 3 
Max. Force 
Wingate 
Pre test La: 
~~~~-
RPM at start : 
Time 
RPM 
Power 
Peak power (W) 
Minimum power (W) 
Average power (W) 
Power drop (W/s) 
Post test La: 
5 
-~~~-
HR: ___ _ 
10 15 
Peak power/kg (W /kg) 
Minimum power/kg (W /kg) 
Average power/kg (Wikg) 
Power drop/kg (W /slkg) 
HR: ___ _ 
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20 
ID: ____ ~ 
25 30 
Name: __________________ __ Group: ________ _ 
Day3 
Date: 
Creatine Kinase 
Muscle Soreness 
Soreness 
Left 
Right 
Tenderness 
Left 
Right 
Strength 
Rep I 
Rep2 
Rep 3 
Max. Force 
Gluteals 
Wingate 
Pre test La: 
I 
I 
Time: ____________ _ 
Quad Hamstring Calf A. Tib 
I I 
I I 
Extensors Flexors 
Left Right Left Right 
HR: 
~~~~-
RPM at start : 
Time 
RPM 
Power 
Peak power (\V) 
Minimum power (Vi) 
Average power (W) 
Power drop (W/s) 
Post test La: 
5 10 15 
Peak power/kg (W /kg) 
Minimum power/kg (W /kg) 
Average power/kg (W/kg) 
Power drop/kg (W /s/kg) 
HR: 
63 
20 
ID: ____ _ 
25 30 
Name: ~------------------- Group: ________ _ 
Day5 
Date: 
Creatine Kinase 
Muscle Soreness 
Soreness 
Left 
Right 
Tenderness 
Left 
Right 
Strength 
Gluteals 
Time: ~-------------
Quad Hamstring Calf A Tib 
I I 
Extensors Flexors 
Left Right Left Right 
Rep I 
Rep2 
Rep 3 
Max. Force 
Wingate 
Pre test La: 
-------------
RPM at start : 
Time 
RPM 
Power 
Peak power (W) 
Minimum power (W) 
Average power (W) 
Power drop (W/s) 
Post test La: 
5 
-------------
HR: -------
10 15 
Peak power/kg (W /kg) 
Minimum power/kg (Wikg) 
Average power/kg (W/kg) 
Power drop/kg (W /s/kg) 
HR: -------
64 
20 
ID: ______ _ 
25 30 
) 
APPENDIX D INDIVIDUAL SUBJECT DATA 
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Subject Charateristics of Age, Height, Weight and Activi!Y Levels for the Test Grou11 
Test group 
Subject Age Height Weight Activity 
Number (years) (em) (kg) (hrs/week) 
20 180 70 15 
2 19 195 80 5 
3 20 174.5 78.5 4 
4 19 183 69 
5 18 185 70 5 
6 18 186 70 8 
7 20 180 69 2 
Subject Characteristics of Age, Height, Weight and Activi!Y Levels for the Control Group 
Control group 
Subject 
Number 
2 
3 
4 
5 
Age 
(years) 
19 
20 
21 
19 
19 
Height Weight 
(em) (kg) 
187 78 
185 
186 
192 
170 
97 
85 
90 
69 
Activity 
(hrs/week) 
6 
5 
8 
3 
4 
Results of Left Limb Strength Measurements from Baseline Testing for the Combined Sample 
Strength (Nm) 
Left Limb 
Extensors Flexors 
Group Subject Test I Test 2 Test 1 Test 2 
test I 199.47 206.27 102.00 108.80 
test 2 348.07 343.87 158.67 167.73 
test 3 285.60 299.20 163.20 149.60 
test 4 204.00 208.53 122.40 140.53 
test 5 222.13 222.13 95.20 104.27 
test 6 256.13 231.20 133.73 131.47 
test 7 321.53 308.27 172.27 167.73 
control 219.87 235.73 136.00 154.13 
control 2 249.30 249.30 149.60 142.80 
control 3 394.40 388.67 179.07 160.93 
control 4 251.60 249.30 111.07 I 08.80 
control 5 244.80 190.40 129.20 126.93 
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Results of Right Limb Strength Measurements for Baseline Testing for the Combined SamQle 
Strength (Nm) 
Right Limb 
Extensors Flexors 
Group Subject Test I Test 2 Test I Test 2 
test I 235.73 244.80 86.30 124.67 
test 2 296.93 285.60 183.60 156.40 
test 3 278.80 285.60 160.93 158.70 
test 4 190.40 204.00 117.87 120.13 
test 5 235.73 210.80 I 08.80 I 08.80 
test 6 240.27 213.07 145.07 133.73 
test 7 244.80 242.53 170.00 176.80 
control 217.60 249.33 165.47 172.27 
control 2 290.13 281.07 136.00 133.73 
control 3 361.67 357.13 174.53 167.73 
control 4 240.27 244.80 111.07 108.80 
control 5 276.53 244.80 145.07 126.93 
Results of Power Ou!Qut from Baseline Testing for the Combined SamQle Groug 
Power Output (W) 
Peak power Average Power 
Group Subject Test I Test 2 Test I Test 2 
test I 633.52 632.77 525.17 507.33 
test 2 698.41 808.59 573.25 617.65 
test 3 666.09 799.91 553.63 579.36 
test 4 614.28 632.76 442.99 466.62 
test 5 592.20 605.10 538.86 528.22 
test 6 610.59 603.63 526.85 498.51 
test 7 657.81 680.55 558.43 549.56 
control 670.39 704.54 576.04 548.64 
control 2 756.60 761.98 664.45 670.67 
control 3 859.96 950.78 688.92 695.37 
control 4 733.63 750.03 524.61 507.31 
control 5 641.42 724.99 488.05 530.68 
Heart Rate Recordings for each 8 Minute Period During the Treadmill Run for the Test GrouQ 
Heart rate (bpm) 
Run Period 
Subject I 2 3 4 5 
I 152 161 162 162 161 
2 143 163 164 166 171 
3 156 160 164 169 165 
4 !58 160 145 150 155 
5 160 163 164 162 !58 
6 159 154 153 158 148 
7 151 159 162 166 163 
Recordings for Running SQeed for each 8 Minute Period During the Treadmill Run for the 
Test GrouQ 
Running Speed (km/hr) 
Run Period 
Subject I 2 3 4 5 
1 15.30 15.30 14.49 13.36 13.36 
2 12.08 14.01 13.36 12.53 12.08 
3 15.30 15.50 15.30 14.17 12.88 
4 13.28 12.08 8.86 8.86 8.86 
5 12.48 14.89 13.97 13.69 13.69 
6 9.47 10.27 10.47 10.79 10.79 
7 11.27 12.88 12.88 12.88 12.88 
Results for Pre- and Post-run Lactate Recordings for the Test Group 
Lactate (mmor') 
Subject Pre-run Post-run 
l 2.20 2.00 
2 2.40 2.00 
3 1.60 4.00 
4 3.90 4.90 
5 3.60 4.60 
6 3.90 3.70 
7 3.00 6.00 
Recordings Across Time of Left Leg Extensor Strength for the Test and Control Grou2s 
Left Leg Extensor Strength (N m/kg) 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test l 2.95 2.49 2.98 3.08 3.69 
test 2 4.35 4.29 4.07 4.52 4.80 
test 3 3.81 2.74 2.89 3.21 3.78 
test 4 3.02 2.69 2.86 3.74 3.81 
test 5 3.17 2.46 2.79 3.08 3.43 
test 6 3.66 2.91 3.27 3.43 3.37 
test 7 4.66 3.94 4.27 4.60 4.34 
control l 3.02 2.96 3.49 3.25 3.60 
control 2 2.57 2.79 3.08 3.06 3.08 
control 3 4.64 4.57 4.31 4.44 4.47 
control 4 2.80 2.95 2.95 3.10 3.17 
control 5 3.55 3.15 3.15 3.12 2.73 
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Recordings Across Time of Right Leg Extensor Strength for the Test and Control GrouQs 
Right Leg Extensor Strength (Nm/kg) 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test I 3.50 2.49 2.78 3.08 3.79 
test 2 3.71 4.07 3.74 4.24 4.24 
test 3 3.64 2.45 2.60 3.12 3.67 
test 4 2.96 2.76 3.02 3.35 3.58 
test 5 3.37 2.23 2.43 2.72 3.37 
test 6 3.43 2.98 3.30 3.11 2.91 
test 7 3.55 3.02 3.25 3.71 3.51 
control 3.20 3.17 3.66 3.31 3.31 
control 2 2.99 3.20 3.34 3.29 3.55 
control 3 4.25 4.04 4.41 4.33 4.25 
control 4 2.72 2.77 2.72 2.97 3.02 
control 5 4.01 3.68 3.09 3.55 3.68 
Recordings Across Time of Left Leg Flexor Strength for the Test and Control GrouQs 
Left Leg Flexor Strength (Nm/kg) 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test I 1.55 1.36 1.88 1.91 2.07 
test 2 2.10 2.03 1.84 2.27 2.15 
test 3 2.08 1.62 1.70 1.65 1.79 
test 4 2.04 1.97 1.97 2.07 1.93 
test 5 1.49 1.52 1.53 1.55 1.55 
test 6 1.91 1.55 1.59 1.49 1.46 
test 7 2.50 2.10 2.17 2.17 2.27 
control I 1.98 1.95 1.92 2.06 1.98 
control 2 1.54 1.54 1.47 1.57 1.61 
control 3 2.11 1.92 1.92 1.87 1.92 
control 4 1.23 1.13 1.28 1.31 1.36 
control 5 1.87 1.91 1.71 1.58 1.35 
Recordings Across Time of Right Leg Flexor Strength for the Test and Control GroUQS 
Right Leg Flexor Stength (Nm/kg) 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test I 1.78 1.91 1.94 2.01 2.14 
test 2 2.30 2.04 1.98 2.21 2.30 
test 3 2.05 1.85 1.73 1.39 1.79 
test 4 1.74 1.61 1.64 1.97 1.97 
test 5 1.55 1.49 1.51 1.55 1.55 
test 6 2.07 1.68 1.49 1.65 1.78 
test 7 2.56 2.14 2.30 2.20 2.14 
control 2.21 2.12 2.21 2.30 1.86 
control 2 1.40 1.59 1.45 1.45 1.54 
control 3 2.05 1.97 1.81 1.92 I. 71 
control 4 1.23 1.21 1.21 1.23 1.46 
control 5 2.10 1.74 69 1.71 1.61 1.68 
Recordings Across Time of Extensor Strength for the Test and Control Groups 
Extensor Strength (Nm/kg) 
Group Subject Baseline Post-run 24 hours ·72 hours 120 hours 
test I 3.22 2.49 2.88 3.08 3.74 
test 2 4.03 4.18 3.91 4.38 4.52 
test 3 3.72 2.60 2.74 3.16 3.72 
test 4 2.99 2.73 2.94 3.55 3.70 
test 5 3.27 2.35 2.61 2.90 3.40 
test 6 3.55 2.95 3.29 3.27 3.14 
test 7 4.10 3.48 3.76 4.16 3.93 
control 3.11 3.07 3.57 3.28 3.46 
control 2 2.78 3.00 3.21 3.18 3.31 
control 3 4.45 4.31 4.36 4.39 4.36 
control 4 2.76 2.86 2.83 3.03 3.10 
control 5 3.78 3.42 3.12 3.34 3.20 
Recordings Across Time of Flexor Strength for the Test and Control Groups 
Flexor Strength (Nm/kg) 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test I 1.67 1.64 1.91 1.96 2.10 
test 2 2.20 2.03 1.91 2.24 2.22 
test 3 2.06 1.73 1.72 1.52 1.79 
test 4 1.89 1.79 1.81 2.02 1.95 
test 5 1.52 1.51 1.52 1.55 1.55 
test 6 1.99 1.62 1.54 1.57 1.62 
test 7 2.53 2.12 2.23 2.18 2.20 
control 2.09 2.03 2.06 2.18 1.92 
control 2 1.47 1.57 1.46 1.51 1.58 
control 3 2.08 1.95 1.87 1.89 1.81 
control 4 1.23 1.17 1.25 1.27 1.41 
control 5 1.99 1.82 1.71 1.59 1.51 
Recordings Across Time of Peak Power for the Test and Control Groups 
Peak Power (W/kg) 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test l 9.05 9.47 8.27 9.66 10.17 
test 2 10.11 9.37 9.81 11.44 11.26 
test 3 10.26 9.45 9.79 9.43 10.24 
test 4 9.17 8.47 8.99 8.96 9.06 
test 5 8.64 8.41 8.41 8.49 9.17 
test 6 8.72 8.60 9.09 9.37 8.84 
test 7 9.86 9.62 9.86 10.15 10.30 
control 9.15 8.71 9.15 9.14 9.78 
control 2 7.86 8.30 8.84 8.90 8.95 
control 3 11.19 11,04 10.56 11.04 10.59 
control 4 8.33 8.04 8.62 8.22 8.16 
control 5 l 0.51 10.51 10.37 9.90 10.62 
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Recordings Across Time of Average Power for the Test and Control GronJ)s 
Average Power (W /kg) 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test 1 7.50 7.22 7.21 7.56 7.49 
test 2 7.72 7.61 7.71 8.17 8.07 
test 3 7.43 6.45 6.62 6.84 7.29 
test 4 6.76 6.43 6.26 6.14 6.15 
test 5 7.55 7.02 7.03 7.15 7.18 
test 6 7.53 7.08 7.41 7.58 7.44 
test 7 7.96 7.88 8.19 8.04 8.09 
control 7.13 7.34 7.63 7.82 7.90 
control 2 6.91 6.81 6.37 6.65 6.83 
control 3 8.18 8.19 7.91 7.75 8.08 
control 4 5.64 5.69 5.68 5.84 5.69 
control 5 7.69 7.60 7.45 7.11 7.51 
Pre-Wingate Lactate Recordings Across Time for the Test and Control_ Gron!)S . 
Pre-test lactate (mmor') 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test I 2.70 2.10 2.00 2.50 2.40 
test 2 2.60 2.90 2.00 3.00 4.00 
test 3 2.10 3.60 1.70 1.80 2.80 
test 4 3.60 3.70 2.70 2.10 2.00 
test 5 4.50 3.60 3.30 2.20 4.10 
test 6 4.50 4.30 5.40 5.00 4.20 
test 7 5.00 5.40 4.80 4.60 4.60 
control 3.30 5.00 4.70 5.00 4.00 
control 2 2.70 2.60 2.70 3.10 2.20 
control 3 4.70 5.00 4.60 4.50 4.20 
control 4 4.50 4.50 4.10 4.90 5.10 
control 5 4.50 5.00 4.50 5.10 4.40 
Post-Wingate Lactate Recordings Across Time for the Test and Cono·ol GroUQS 
Post-test lactate (mmor') 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test I 8.90 10.30 13.30 9.80 11.10 
test 2 13.00 12.50 10.80 13.20 8.20 
test 3 13.20 10.00 9.40 13.40 12.20 
test 4 11.80 11.00 11.20 11.80 11.90 
test 5 14.20 10.70 9.00 11.30 11.60 
test 6 12.30 11.40 10.10 11.70 11.20 
test 7 11.00 11.90 13.40 11.30 13.20 
control 13.20 13.90 14.20 12.90 14.90 
control 2 6.30 6.20 6.20 7.60 7.30 
control 3 13.70 12.20 12.70 12.00 12.50 
control 4 11.20 11.40 10.60 10.50 14.70 
control 5 14.30 12.20 12.30 12.10 12.50 
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Pre-Wingate Heart Rate Recordings Across Time for the Test and Control Grougs 
Pre-test heart rate (bpm) 
Group Subject Baseline Post-run 24 hours .72 hours 120 hours 
test I 96 83 94 70 75 
test 2 84 92 86 86 74 
test 3 85 108 76 74 91 
test 4 78 74 94 79 S6 
test 5 74 72 70 60 66 
test 6 99 96 104 104 94 
test 7 106 83 94 91 9S 
control 96 100 106 93 106 
control 2 108 9S S7 106 9S 
control 3 116 Ill 99 liS 110 
control 4 112 102 97 102 97 
control 5 102 105 86 96 98 
Post-Wingate Heart Rate Recordings Across Time for the Test and Control GroUQS 
Post-test heart rate (bpm) 
Group Subject Baseline Post-run 24 hours 72 hours 120 hours 
test I 160 169 161 163 170 
test 2 163 179 170 169 185 
test 3 183 173 175 175 ISO 
test 4 179 175 181 JS2 180 
test 5 JS6 181 182 186 179 
test 6 190 ISO 191 IS7 181 
test 7 197 184 183 195 197 
control 186 JS9 192 190 190 
control 2 159 164 156 163 163 
control 3 179 172 1S3 1S6 1Sl 
control 4 173 173 173 170 171 
control 5 197 197 193 190 194 
Recordings Across Time of Plasma CK for the Test and Control Grougs 
Plasma CK (U/1) 
Group Subject Pre-run Post-run 24 hours 72 hours 120 hours 
test 1 210 2S4 741 373 288 
test 2 285 292 641 2S3 35S 
test 3 130 229 511 199 349 
test 4 70 102 116 53.3 73 
test 5 32.30 61.5 19S S6.9 179 
test 6 70.50 61.8 221 137 122 
test 7 300.00 420 1630 563 571 
control I 9S.2 104 72.1 72.3 
control 2 70.6 86.2 72.9 85.2 
control 3 173 130 133 178 
control 4 54.7 95.8 49.2 39.1 
control 5 179 133 171 179 
Pre-run Recordings of Soreness in the Left Leg for the Test GrouQ 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 
2 I I 1.5 1.5 
3 I I I I 
4 
5 
6 
7 
Pre-run Recordings of Soreness in the Right Leg for the Test GrouQ 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
.__, I 
w 2 I I 1.5 1.5 
3 
4 
5 
6 I I I I I I I I I I I 
7 I 3 I I I I I I I 1.5 
Pre-run Recordings of Tenderness in the Left Leg for the Test GrouQ 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 100 100 100 100 100 100 100 100 100 100 100 
2 100 100 100 100 100 100 100 100 100 100 100 
3 100 100 100 100 100 100 100 100 100 100 100 
4 100 100 100 100 100 100 100 100 100 100 100 
5 100 100 100 I 00 100 100 100 100 100 100 100 
6 100 100 100 100 100 100 100 100 100 100 100 
7 100 100 100 100 100 100 100 100 100 100 100 
Pre-run Recordings of Tenderness in the Right Leg for the Test Grou12 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 100 100 100 100 100 100 100 100 100 100 100 
2 100 100 100 100 100 100 100 100 100 100 100 
3 100 100 100 100 100 100 100 100 100 100 100 
4 100 100 100 100 100 100 100 100 100 100 100 
5 100 100 100 100 100 100 100 100 100 100 100 
6 100 100 100 100 100 100 100 100 100 100 100 
7 100 100 100 100 100 100 100 100 100 100 100 
Post-run Recordings of Soreness in the Left Leg for the Test GrouQ 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Pro·ximal Medial Lateral A. Tib 
_, I 7 7 6.5 I I I I I I 
_,. 
2 I I I I I I I I 8 8 
3 I 6 I 2 I I I I 4 5 I 
4 I I I I I I I I 6 6 2 
5 I 2 3 I I 2 I I 4 4 3 
6 I I I I I I I I 3 I I 
7 I I I I I I I 5 
Post-run Recordings of Soreness in the Right Leg for the Test Grou12 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I I I 6.5 I I I I I I I 
2 I I I I I I I I 8 8 
3 I I I 5 I I I I 3 I I 
4 I I I I I I I I 6 6 2 
5 I 2 3 I I 2 I I 4 4 3 
6 I I 3 I I I I 3 3 
7 I 4 I I I I I 5 
Post-run Recordings of Tenderness in the Left Leg for the Test GrOUQ 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 100 100 100 100 100 100 100 100 100 100 100 
2 100 100 100 100 100 100 100 100 100 100 100 
3 100 100 100 100 100 100 100 100 100 100 100 
4 100 100 100 100 100 100 100 100 100 100 100 
5 100 100 100 100 100 100 100 100 100 100 100 
6 100 100 100 100 100 100 100 100 100 100 100 
7 100 100 100 100 100 100 100 100 100 100 100 
Post-run Recordings of Tenderness in the Right Leg for the Test Grou[! 
G1utea1s Quads Hamstrings Calf 
--·---
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
-.1 
I 100 100 100 100 100 100 100 100 100 100 100 
"' 2 100 100 100 100 100 100 100 100 100 100 100 
3 100 100 100 100 100 100 100 100 100 100 100 
4 100 100 100 100 100 100 100 100 100 100 100 
5 100 100 100 100 100 100 100 100 100 100 100 
6 100 100 100 100 100 100 100 100 100 100 100 
7 100 100 100 100 100 100 100 100 100 100 100 
Recordings of Soreness in the Lelt Leg for the Te~1 Grou(;! 24 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I I I 8 5 I I 1 I I I 2 
2 I 4 2 I I I I I 4 6 
3 I 6 4 3 5 2 2 2 3 6 3 
4 5 5 I I 3 I 1 3 8 4 4 
5 I 6 6 6 6 3 4 3 I 6 
6 3 3 5 5 5 5 5 5 3 
7 5 5 I I I I I 
Recordings of Soreness in the Right Leg for the Test GrouQ 24 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 7 7 8 5 I I I I I I 2 
2 I 4 2 I I I I I 4 6 
3 I 6 4 3 5 2 2 2 3 6 3 
4 5 5 I I 3 3 3 3 8 4 4 
5 I 6 6 6 6 3 4 3 I 6 I 
6 3 3 5 5 5 5 5 5 3 
7 5 5 
Recordings. of Tenderness in the Lefl Leg for the Test Grou12 24 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Pro-ximal Medial Lateral A.Tib 
_, I 100 100 5 5 5 100 100 100 100 100 25 
'"' 
2 100 5 100 100 100 100 100 100 100 100 100 
3 30 80 5 20 5 35 65 35 60 25 5 
4 50 45 30 35 40 70 50 20 35 20 55 
5 100 60 70 50 10 40 50 40 60 5 70 
6 70 40 5 40 10 60 40 50 40 60 90 
7 90 80 80 50 60 80 80 90 60 50 80 
Recordings of Tenderness in the Right Leg for the Test GrouQ 24 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 100 100 5 5 5 100 100 100 100 100 25 
2 100 5 100 100 100 100 100 100 100 100 100 
3 20 80 5 5 5 35 40 20 20 20 5 
4 45 50 5 35 30 60 50 40 40 40 15 
5 100 60 90 40 20 60 60 25 50 5 60 
6 90 40 5 30 40 50 20 40 50 50 100 
7 90 60 50 50 20 80 60 20 90 70 80 
Recordings of Soreness in the Len Leg for the Test GrouQ 72 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 1.5 1.5 7.5 8 6.5 I I I I I 2 
2 1.5 1.5 I I I I I I 3 3 
3 I I 5 3 3 I I I 2 3 
4 I I 2 2 I I I I 3 I 2 
5 I 3 5 5 5 I I I 3 I I 
6 4 4 5 5 I 5 5 I I 4 
7 I I I I I I I 2 
Recordings of Soreness in the Right Leg for the Test GrouQ 72 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subje~.::t Medial Lateral Medial Lateral Proximal Medial Lateral ProXimal Medial Lateral A. Tib 
__, I 1.5 1.5 7.5 8 6.5 I I I I I 2 
__, 2 1.5 1.5 I I I I I I 3 3 
3 I I 4 3 3 I I I 2 3 
4 I I 2 2 I I I I 3 I 2 
5 I 3 5 5 5 I I I 3 
6 4 4 5 5 I 5 5 I I 4 .I 
7 5 5 I I I I I I I I I 
Recordings of Tenderness in the Left Leg for the Test GrouQ 72 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 100 100 30 25 25 100 100 100 IOO IOO 15 
2 100 100 100 IOO 100 100 100 100 100 100 100 
3 100 70 5 40 5 40 40 20 45 40 5 
4 100 100 50 50 50 50 60 60 80 100 65 
5 100 95 20 70 10 70 80 40 70 50 IOO 
6 80 40 5 45 35 40 40 55 50 50 70 
7 95 70 70 55 80 100 80 80 25 65 100 
Recordings of Tenderness in the Right Leg for the Test GrouJ272 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I 100 100 30 25 25 100 100 100 100 100 15 
2 100 100 100 100 100 100 100 100 100 100 100 
3 100 30 5 45 5 50 50 30 60 20 5 
4 100 100 30 65 70 50 60 50 70 100 50 
5 100 70 20 25 15 100 100 100 85 100 100 
6 80 40 15 20 60 50 60 60 80 50 100 
7 100 70 80 50 40 100 100 60 30 70 100 
Recordings of Soreness in the Left Leg for the Test GrouQ 120 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I I I 3 3 3 I I I I I 
__, 
00 2 I I I I I I I I 1.5 1.5 
3 I I I I 3 
4 I I I I I I I I 2 I 2 
5 I I I I 2 
6 I I I I 2 I I 2.5 
7 I I I I I 
Recordings of Soreness in the Right Lee for the Test GrouQ 120 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A. Tib 
I I I 3 3 3 
2 I I I I I I I I 1.5 1.5 I 
3 I I I I 3 I I I I I I 
4 I I I I I I I I 2 I 2 
5 I I I I 2 
6 I I I I 2 I I 2.5 
7 3.5 3.5 I I I I I I 
Recordings of Tenderness in the Left Leg for the Test GrouQ 120 hours Post-run 
GIUteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A.Tib 
I 100 100 100 100 100 100 100 100 100 100 100 
2 100 100 100 100 100 100 100 100 100 100 100 
3 100 100 60 45 50 40 40 5 60 40 30 
4 100 100 100 100 100 100 100 100 100 100 100 
5 100 100 100 100 100 100 100 100 100 100 100 
6 100 100 100 100 100 100 100 100 100 100 100 
7 95 80 100 100 100 !00 100 100 100 100 100 
Recordings· of Tenderness in the Right Leg for the Test GrOUQ 120 hours Post-run 
Gluteals Quads Hamstrings Calf 
Subject Medial Lateral Medial Lateral Proximal Medial Lateral Proximal Medial Lateral A.Tib 
__, I 100 100 100 100 100 100 100 100 100 100 100 
"' 2 100 100 100 100 100 100 100 100 100 100 100 
3 100 100 45 40 60 40 30 5 60 30 35 
4 100 100 100 100 100 100 100 100 100 100 100 
5 100 100 100 100 100 100 100 100 100 100 100 
6 100 100 100 100 100 100 100 100 100 100 100 
7 95 85 100 100 100 100 100 100 100 100 100 
